Renal Artery Denervation is Approved and Has a Fee Code - This is Only the Start of a Potentially Massive Opportunity for Procedural Growth That IR Must Be a Part Of

Monday, March 31, 2025

1:15 PM – 2:30 PM CT

Location: Music City Center, 205 BC

Content Level: 300 (advanced)

Coordinator(s)

Lindsay Machan, MD, FSIR

Associate Professor
University of British Columbia, Canada
Marc Sapoval, MD, PhD

Head vascular and Oncological Interventional Radiology
Hopital Europeen Georges Pompidou, France

Approximately 30% of US adults have hypertension, less than 50% overall are well controlled. Two renal artery denervation (RDN) devices for treatment of hypertension are now FDA approved. Tips on practice building and RDN procedural technique will be presented. In addition to hypertension, sympathetic overactivity has been shown to contribute to insulin resistance, metabolic syndrome, obstructive sleep apnea, heart failure and renal disease. Applications of denervation to a broad variety of common conditions will be described, most of which are ideally suited to IR skill sets.

Learning Objectives:

Upon completion, participant will be able to describe the indications for, and procedure of, renal artery denervation.
Upon completion, participant will be able to list the technologies available for renal artery denervation and understand potential advantages and disadvantages of each.
Upon completion, participant will be able to discuss applications of image guided denervation to other common diseases where sympathetic overactivity is a contributor.

Presentations:

1:15 PM – 1:25 PM CT

Renal Denervation Has Resurfaced - What IR's Need to Know
Speaker: Lindsay Machan, MD, FSIR – University of British Columbia
1:25 PM – 1:35 PM CT

The Role of Renal Artery Denervation in Hypertension Management - The clinician's Perspective
Co-Speaker: Lindsay Machan, MD, FSIR – University of British Columbia
Author/Co-author: Raymond Townsend, MD – University of Pennsylvania
1:35 PM – 1:45 PM CT

Renal Artery Denervation by Focused Ultrasound and Radiofrequency Ablation
Speaker: Marc Sapoval, MD, PhD – Hopital Europeen Georges Pompidou
1:45 PM – 1:55 PM CT

Patient Selection and Practice Building Tips for Renal Artery Denervation
Speaker: Lindsay Machan, MD, FSIR – University of British Columbia
1:55 PM – 2:05 PM CT

Applications of Image Guided Neuromodulation Beyond Hypertension
Speaker: Gao-Jun Teng, MD, FSIR – Zhong-Da Hospital, Southeast University
2:05 PM – 2:15 PM CT

Research Behind Renal Denervation
Speaker: Sanjay Misra, MD – Mayo Clinic & Foundation
2:15 PM – 2:30 PM CT

Q&A